involving modified dna conducted united states stadtmauer team convince regulators review boards institutions allow trial immunologist carl june university pennsylvania science adviser project says begin end year trials not far cambridge massachusetts instance said wants use crispr clinical trial rare form blindness soon 2017 rac members not approached reviewing trial crispr courted attention ease use t cell trial not test efficacy gene editing fight diseases 2014 june led trial different gene editing system called zinc finger nuclease group took blood 12 people hiv removed gene encodes protein t cells targeted virus hoped prevent infection cells results encouraging technique clinical trials